Evidence map›Paper›PMID 20011100›Full record

ArticlePLoS genetics2009

SOS response induces persistence to fluoroquinolones in Escherichia coli.

Tobias Dörr, Kim Lewis, Marin Vulić

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 293 papers.

0numbers the graph read from it
0cells of the map it votes in
293citing papers in PubMed
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

293 citing papers in PubMed, 522 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Glycerol-Driven Energy and Proteostasis Underpin Antibiotic Tolerance inbioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Identification of a novel gene inAntimicrobial agents and chemotherapy · 2026
    Article
  17. The Role of the SOS Response in the Adaptation ofCurrent issues in molecular biology · 2026
    Review
  18. Article
  19. Article
  20. Review

233 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tobias DörrAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.
Kim Lewis
Marin Vulić
Northeastern University · US

Funding

A GENOMICS APPROACH TO P. AERUGINOSA BIOFILMSR01GM061162 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI LEWIS, KIM · 2000 to 2011
$4.2M
NIGMS NIH HHS 3R01 GM061162-05A1NIGMS NIH HHS R01 GM061162
6 · The paper itself

Abstract

Bacteria can survive antibiotic treatment without acquiring heritable antibiotic resistance. We investigated persistence to the fluoroquinolone ciprofloxacin in Escherichia coli. Our data show that a majority of persisters to ciprofloxacin were formed upon exposure to the antibiotic, in a manner dependent on the SOS gene network. These findings reveal an active and inducible mechanism of persister formation mediated by the SOS response, challenging the prevailing view that persisters are pre-existing and formed purely by stochastic means. SOS-induced persistence is a novel mechanism by which cells can counteract DNA damage and promote survival to fluoroquinolones. This unique survival mechanism may be an important factor influencing the outcome of antibiotic therapy in vivo.

Indexed as

SOS Response, GeneticsAnti-Bacterial AgentsCiprofloxacinDrug Resistance, MicrobialEscherichia coliStochastic ProcessesAnti-Bacterial AgentsCiprofloxacin

Identifiers

PMID20011100
PMCPMC2780357
OpenAlexW2101366952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.